Blog

Sep 13, 2023

Atezolizumab approved for advanced alveolar soft part sarcoma

Posted by in category: biotech/medical

A clinical trial led by NCI has resulted in FDA approval of the immunotherapy drug atezolizumab (Tecentriq) to treat advanced alveolar soft part sarcoma.

Comments are closed.